In Q1 2023, RTW Investments held 45 positions worth $4.3B. They initiated 45 new positions. Their largest holding was RXDX ($351.2M).
Frequently asked questions
What stocks did RTW Investments own in Q1 2023?
RTW Investments held 45 biotech stocks in their 13F portfolio in Q1 2023. Their top positions include RXDX, PTCT, ALNY, RCKT, IMCR. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was RTW Investments's portfolio worth in Q1 2023?
RTW Investments's tracked biotech portfolio was worth $4.3B across 45 positions, with total assets under management of approximately $10B. Portfolio values are based on 13F filings with the SEC.
What did RTW Investments buy in Q1 2023?
RTW Investments initiated 45 new positions in Q1 2023, including RXDX, PTCT, ALNY, RCKT, IMCR and 40 more. They also increased 0 existing positions.
What did RTW Investments sell in Q1 2023?
RTW Investments did not fully exit any positions in Q1 2023.
Is RTW Investments a biotech fund?
Data-driven biotech fund led by a physician-investor who combines clinical expertise with quantitative analysis. RTW takes concentrated positions across the biotech lifecycle, from crossover privates to public equities, with a focus on therapeutic areas where clinical data can be independently modeled.
Want AI analysis, insider signals, and catalyst overlays for RTW Investments?
View latest RTW Investments portfolio →